Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea · Delayed Price · Currency is KRW 30,300
+400 (1.34%)
At close: Dec 5, 2025
Daihan Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 31,556 | 33,759 | 28,426 | 24,961 | 22,670 | 17,381 | Upgrade |
Depreciation & Amortization | 8,166 | 7,282 | 8,663 | 9,208 | 11,411 | 11,300 | Upgrade |
Loss (Gain) From Sale of Assets | -48.97 | -58.03 | -22.53 | 9.4 | -41.28 | -19.72 | Upgrade |
Loss (Gain) From Sale of Investments | -485.59 | -303.6 | -288.69 | - | - | - | Upgrade |
Provision & Write-off of Bad Debts | 82.92 | 17.05 | 10.8 | -33.29 | -142.8 | -319.09 | Upgrade |
Other Operating Activities | 2,444 | 2,115 | 4,194 | 2,632 | 7,386 | 8,587 | Upgrade |
Change in Accounts Receivable | -1,727 | -385.22 | 437.93 | -2,172 | -10.94 | 7,321 | Upgrade |
Change in Inventory | -7,499 | -3,194 | 1,271 | -4,407 | 2,969 | -3,812 | Upgrade |
Change in Accounts Payable | 2,702 | 526.47 | -877.61 | 2,997 | -389.71 | -455.66 | Upgrade |
Change in Other Net Operating Assets | -2,794 | -4,115 | -2,954 | -4,194 | -3,234 | -6,355 | Upgrade |
Operating Cash Flow | 32,397 | 35,643 | 38,860 | 28,999 | 40,617 | 33,627 | Upgrade |
Operating Cash Flow Growth | -12.46% | -8.28% | 34.00% | -28.60% | 20.79% | -4.64% | Upgrade |
Capital Expenditures | -28,190 | -15,801 | -21,280 | -8,621 | -11,850 | -5,360 | Upgrade |
Sale of Property, Plant & Equipment | 48.99 | 58.04 | 22.53 | - | 41.66 | 26.81 | Upgrade |
Investment in Securities | -23,240 | -56,883 | 3,235 | 8,635 | 283.86 | -5,595 | Upgrade |
Other Investing Activities | 0 | 0 | 25 | 180 | 10 | -9 | Upgrade |
Investing Cash Flow | -51,381 | -72,626 | -17,998 | 193.48 | -11,515 | -10,938 | Upgrade |
Short-Term Debt Repaid | - | - | -2,500 | -200 | -1,000 | -1,300 | Upgrade |
Long-Term Debt Repaid | - | -38.79 | -4,080 | -16,817 | -4,300 | -2,301 | Upgrade |
Total Debt Repaid | -66.78 | -38.79 | -6,580 | -17,017 | -5,300 | -3,601 | Upgrade |
Net Debt Issued (Repaid) | -66.78 | -38.79 | -6,580 | -17,017 | -5,300 | -3,601 | Upgrade |
Repurchase of Common Stock | - | - | - | -3,418 | - | - | Upgrade |
Dividends Paid | -5,195 | -4,329 | -3,752 | -2,108 | -2,108 | -2,108 | Upgrade |
Financing Cash Flow | -5,262 | -4,368 | -10,332 | -22,543 | -7,408 | -5,709 | Upgrade |
Foreign Exchange Rate Adjustments | 970.21 | 1,152 | 113.04 | 441.94 | 671.96 | -418.12 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | 0 | -0 | 0 | Upgrade |
Net Cash Flow | -23,275 | -40,199 | 10,644 | 7,092 | 22,367 | 16,562 | Upgrade |
Free Cash Flow | 4,207 | 19,841 | 17,580 | 20,378 | 28,767 | 28,267 | Upgrade |
Free Cash Flow Growth | -73.02% | 12.86% | -13.73% | -29.16% | 1.77% | 57.40% | Upgrade |
Free Cash Flow Margin | 2.01% | 9.72% | 8.97% | 11.06% | 16.78% | 17.02% | Upgrade |
Free Cash Flow Per Share | - | 3374.38 | 2989.79 | 3405.01 | 4794.57 | 4711.20 | Upgrade |
Cash Interest Paid | 3.67 | 1.81 | 52.47 | 582.23 | 451.55 | 596.73 | Upgrade |
Cash Income Tax Paid | 7,952 | 8,028 | 8,656 | 8,869 | 3,247 | 8,022 | Upgrade |
Levered Free Cash Flow | -2,136 | 12,013 | 13,570 | 17,249 | 25,715 | 23,070 | Upgrade |
Unlevered Free Cash Flow | -2,133 | 12,014 | 13,603 | 17,620 | 26,009 | 23,456 | Upgrade |
Change in Working Capital | -9,317 | -7,168 | -2,123 | -7,777 | -665.87 | -3,302 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.